As of May 27, 2020, there were over 1,678,843 confirmed cases of COVID-19 claiming more than 100,000 lives in the Unites States. (Cases in the U.S, 2020) Currently there is no known effective therapy or vaccine. The urgent need for therapeutic agents has resulted in repurposing and redeployment of experimental agents (McCreary and Pogue, 2020; Sanders et al., 2020).
The emergence of SARS-CoV-2 causing the prolonged COVID-19 pandemic has had profound public health and socioeconomic consequences worldwide [1]. Throughout the course of the pandemic,…
Post-influenza bacterial pneumonia is a major cause of morbidity and mortality associated with both seasonal and pandemic influenza virus illness. However, despite much interest in…
To evaluate the efficacy and safety of low dose trimethoprim-sulfamethoxazole (TMP-SMX) as primary prophylaxis for Pneumocystis jirovecii pneumonia (PJP) in adult kidney transplantation recipients.
Since January 2022, and as of July 19th 2022, a total of 14.179 cases laboratory-confirmed cases of monkeypox, including one death, have been reported to…
Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis (MTB) in humans, poses a major threat to human health (World Health Organization, 2021), ranking among the top…
Since January 2022, and as of 15th June 2022, a total of 2103 laboratory-confirmed cases of monkeypox, including one death, have been reported to the…
